Baxter Announces FDA Approval of
Selected Abstract
Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit.
The first hemostasis kit combines two important surgical tools: Baxter's human thrombin and Pfizer's GELFOAM DEERFIELD, Ill., Dec. 17 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced the Food and Drug Administration approval of GELFOAM(R) Plus Hemostasis Kit (absorbable ... December 17, 2007; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Baxter Announces FDA Approval Of Ceprotin.
2.
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients.
3.
tin For Severe Congential Protein C Deficiency.
4.
Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit.
|
